| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Revenue and operating profit grew together, indicating healthy core operations.
Operating margin improved by 3.98 percentage points year over year.
- Revenue
- USD 7.42B YoY +6.00%
- Largest revenue segment share (Chemicals)
- 20.17% YoY +0.18pp
- Income tax expense
- USD 574.00M Share 7.74% · YoY +20.59%
View calculation evidence
YoY periods: H1 2026 compared with H1 2025
Source metrics
- Income tax expenseIncome tax expense (benefit) · IncomeTaxExpenseBenefit
- Largest revenue segment share (Chemicals)Chemicals · segment_value / revenue * 100
- Operating marginOperating income · operating_income / revenue * 100
- RevenueRevenue from contract with customer, excluding assessed tax · RevenueFromContractWithCustomerExcludingAssessedTax